Follow the Peak Bio, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 4 December 2024 (J). Among the most active insiders: Huh Hoyoung. All data is openly available.
20
Insider Decl.
n/a
Thresholds
€1,265
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Peak Bio, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
15Σ signal
Buys €1,265n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Peak Bio, Inc. es una empresa centrada en el desarrollo de terapias biológicas innovadoras. Su objetivo es proporcionar soluciones para necesidades médicas graves y no satisfechas.